[{"Assets_0_Q3_USD":1557300000.0,"CIK":"899923","CommonStockSharesConverted_0_Q3_shares":73400000.0,"CommonStockSharesOutstanding_0_Q3_shares":73400000.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":0.09,"EarningsPerShareBasic_3_Q3_USD":0.12,"EarningsPerShareDiluted_1_Q3_USD":0.09,"EarningsPerShareDiluted_3_Q3_USD":0.12,"Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","Market Cap":"1850258412.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":52200000.0,"NetIncomeLossConverted_1_Q3_USD":6900000.0,"NetIncomeLossConverted_3_Q3_USD":8800000.0,"OfficialName":"Myriad Genetics Inc. Common Stock","RevenuesConverted_1_Q3_USD":216600000.0,"RevenuesConverted_3_Q3_USD":635700000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquityConverted_0_Q3_USD":1081700000.0,"StockholdersEquity_0_Q3_USD":1081800000.0,"Ticker":"MYGN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":74900000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":76400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":73300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":73500000.0,"filed":"20190508","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2019.0","name":"MYRIAD GENETICS INC","period":"20190331","qtrs":"0","uom":"USD"}]